2Gollob MH,Seger J J,Gollob TN,et al.Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy[J].Circulation,2001,104(25):3030-3033.
3Blair E,Redwood CS,Ashrafian H,et al.Mutations in the gamma(2) subunit of AMP-activated protein kinase cause hypertrophic cardiomyopathy:evidence For the central role of energy comp disease pathogenesis[J].Hum Mol Genet,2001,10(11):1215-1220.
4MacRae CA,Ghasia N,Gass S,et al.Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3[J].J Clin Invest,1995,96(3):1216-1220.
5Gollob MH,Green MS,Tang AS,et al.Identification of a gene responsible for familial Wolff-Parkinson-Whire syndrome[J].N Engl J Med,2001,344(24):1823-1864.
6Bayrak F,Komurcu-Bayrak E,Mutlu B,et al.Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation[J].Eur J Heart Fail,2006,8(7):712-715.
9Charron P,Genest M,Richard P,et al.A familial form of conduction defect related to a mutation in the PRKAG2 gene[J].Europace,2007,9(8):597-600.
10Murphy RT,Mogensen J,Mcgarry K,et al.Adenosine Monophosphate-Activated Protein Kinase Disease Mimicks Hypertrophic Cardiomyopathy and Wolff-Parkinson-White Syndrome Natural History[J].J Am coll Cardiol,2005,45(6):922-930.
二级参考文献13
1Gollob MH, Seger JJ, Gollob TN,et al. Novel PRKAG2 mutation in the genetic syndrome of ventricular preexcitation and conduction defects with childhood onset and absence of cardiac hypertrophy.Circulation, 2001,104(25) :3030-3033.
2Blair E, Redwood C, Ashrafian H, et al. Mutations in the gamma (2) subunit of AMP activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet,2001,10 ( 11 ) : 1215-1220.
3Gollob MH, Green MS, Tang A, et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med,2001,344(24) :1823-1864.
4Marian AJ, Roberts,s R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol, 2001,33 ( 4 ) :655-670.
5Sternick EB, Oliva A, Magalhaes LP, et al. Familial pseudo-Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol,2006,17 (7) :724-732.
6Arad M, Benson DW, Perez-Atayde AB, et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest, 2002,109(3) :357-362.
7Laforet P, Richard P, Said MA, et al. A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis.Neuromuscul Disord,2006,16(3 ) : 178-182.
8Khair GZ, Soni GS, Bamrah VS. Syncope in hypertrophic cardiomyopathy Ⅱ. coexistence of atrioventricular block and Wolff-Parkinson-White syndrome. Am Heart J, 1985,110 ( 5 ) : 1083-1086.
9Mac Rae CA, Ghaisas N, Kass S, et al. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest, 1995,96 ( 3 ) : 1216- 1220.
10Gollob MH, Green MS, Tang ASL, et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med ,2001,344 ( 24 ) : 1823-1831.
